Medical News

RSS

Royal Holloway University supports Muscular Dystrophy Campaign

Royal Holloway University, is today giving money generated by its research into Duchenne muscular dystrophy to the Muscular Dystrophy Campaign.

27 Mar 2013

Microbiologists identify unique resistance mechanisms of E. coli to carbapenems

As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to carbapenems.

27 Mar 2013

Researcher receives grant to enhance human tissue dissection, reduce blood transfusions during surgery

A George Washington University researcher recently received a grant to study ways to cut human tissue more efficiently, an effort that could minimize the need for blood transfusions and other products for patients during surgery.

27 Mar 2013

POZEN announces submission of NDA for marketing approval of PA32540/PA8140

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for the marketing approval of PA32540/PA8140.

27 Mar 2013

Researchers recommend radiosurgery for treating unruptured arteriovenous malformations

Researchers at the University of Virginia (UVA) Health System recommend radiosurgery for treating unruptured arteriovenous malformations (AVMs), because the procedure has a reasonable benefit-to-risk profile.

27 Mar 2013

Genetic variants influence childhood obesity, say researchers

Previous research has shown that obesity runs in families, and twin studies suggest that this is largely due to genetic factors, with heritability estimates over 50%.

27 Mar 2013

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.

27 Mar 2013

First Edition: March 26, 2013

Today's headlines include reports about a new study estimating how the health law will impact medical claims costs.

27 Mar 2013

Lightlake to present Phase II clinical trial results of opioid antagonist nasal spray at APA Annual Meeting

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing addiction treatments, announced today that a scientific abstract based on results of the Company's Phase II clinical trial of its opioid antagonist nasal spray treatment for patients with Binge Eating Disorder has been accepted for presentation at the American Psychiatric Association Annual Meeting taking place in San Francisco, California, May 18-22, 2013.

27 Mar 2013

Fruit flies raised on organic diets record better health outcomes

A new study looking at the potential health benefits of organic versus non-organic food found that fruit flies fed an organic diet recorded better health outcomes than flies fed a nonorganic diet.

27 Mar 2013

Academic performance linked to risky health behaviors in children and teens

Academic performance is linked to risky health behaviors in children and teens, reports a new review in the Journal of Adolescent Health. Health risks that can impact academic success include behaviors tracked by the Centers for Disease Control (CDC) in young people, such as unhealthy diets, physical inactivity, violence, inappropriate sexual behaviors, and alcohol, drug or tobacco use.

27 Mar 2013

Health Strategy Associates principal comments on impact of opioid use on workers' compensation

Opioids are the biggest problem facing workers' compensation today. This was the message Joseph Paduda, principal of Health Strategy Associates and author of www.ManagedCareMatters.com, delivered at the California Workers' Compensation Institute's annual meeting in San Francisco last week.

27 Mar 2013

Study: Gene therapy can boost heart muscle function

In an animal study, researchers at the University of Washington show that it is possible to use gene therapy to boost heart muscle function. The finding suggests that it might be possible to use this approach to treat patients whose hearts have been weakened by heart attacks and other heart conditions.

27 Mar 2013

Novel sensor improves success rate in diagnosing dysphagia

Those suffering from swallowing difficulties, especially stroke patients, could be evaluated more efficiently and noninvasively thanks to research under way at the University of Pittsburgh and the University of Toronto.

27 Mar 2013

Lancet series examines tuberculosis

"To commemorate World TB Day 2013, the Lancet Infectious Diseases publishes a series of papers on tuberculosis, a disease that has long plagued human beings and was declared a global emergency in 1993 by WHO," the series homepage states.

27 Mar 2013

Stakeholders see health law benefits, challenges

News outlets explore issues emerging from the health law's implementation, including how the costs of insuring full-time employees could be a boon for temporary staffing agencies, how nurse practitioners are seeking a greater role in primary care and how some clinics are fighting to benefit from the law's changes.

27 Mar 2013

Novel molecular mechanism can prevent aging and cancer progression, say researchers

University of Montreal researchers have discovered a novel molecular mechanism that can potentially slows the aging process and may prevent the progression of some cancers.

27 Mar 2013

Study raises alarm over loss of individual 'genomic liberty' due to gene patents

Humans don't "own" their own genes, the cellular chemicsals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially claimed the entire human genome for profit, report two researchers who analyzed the patents on human DNA. Their study, published March 25 in the journal Genome Medicine, raises an alarm about the loss of individual "genomic liberty."

27 Mar 2013

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Shionogi Limited, the London-based European subsidiary of Shionogi & Co., Ltd announced today that on 26th March 2013 the European Medicines Agency accepted its Marketing Authorisation Application submission for ospemifene for the treatment of vulvar and vaginal atrophy in post-menopausal women.

27 Mar 2013

New data reveals impact of opioid-related adverse events on length, cost of hospitalization after surgery

Pacira Pharmaceuticals, Inc. today announced data from a large-scale analysis of a national database of patients from 380 hospitals in the United States who underwent 319,898 inpatient surgeries and received opioids for postsurgical pain management.

27 Mar 2013

Medical News

Royal Holloway University supports Muscular Dystrophy Campaign

Microbiologists identify unique resistance mechanisms of E. coli to carbapenems

Researcher receives grant to enhance human tissue dissection, reduce blood transfusions during surgery

POZEN announces submission of NDA for marketing approval of PA32540/PA8140

Researchers recommend radiosurgery for treating unruptured arteriovenous malformations

Genetic variants influence childhood obesity, say researchers

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

First Edition: March 26, 2013

Lightlake to present Phase II clinical trial results of opioid antagonist nasal spray at APA Annual Meeting

Fruit flies raised on organic diets record better health outcomes

Academic performance linked to risky health behaviors in children and teens

Health Strategy Associates principal comments on impact of opioid use on workers' compensation

Study: Gene therapy can boost heart muscle function

Novel sensor improves success rate in diagnosing dysphagia

Lancet series examines tuberculosis

Stakeholders see health law benefits, challenges

Novel molecular mechanism can prevent aging and cancer progression, say researchers

Study raises alarm over loss of individual 'genomic liberty' due to gene patents

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

New data reveals impact of opioid-related adverse events on length, cost of hospitalization after surgery

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News